To monitor tumor motion during stereotactic body radiotherapy (SBRT) for patients with liver cancer, an integrated ultrasound and kilo-voltage cone-beam computed tomography (KV- CBCT) system has been proposed. The presence of an ultrasound probe may interfere with the radiation beams. The purpose of this study is to minimize this interference by altering orientations of the ultrasound probe and directions of radiation beams while not compromising the quality of SBRT plans. Ten patients, who received SBRT of liver cancer, were randomly selected for this study.
Introduction
Radiotherapy, especially stereotactic body radiation therapy (SBRT), has become a pivot treatment option for patients with liver tumor, who are not eligible for surgery (1) (2) (3) (4) . By delivering larger doses per fraction over a short period of time, SBRT has been successfully used for the treatment of unresectable liver lesions. With stringent immobilization, motion management, and image guidance, SBRT offers the possibility of a high-precision and non-invasive treatment with small planning margins (5) . Phase I-II clinical trials have demonstrated local tumor control rates of 94% and 84% at 1 and 2 years respectively for patients with liver cancer treated with SBRT (6) . Because of respiratory motion, the position of a liver tumor may vary with a typical magnitude of 1 cm to 3 cm during deep inspiration or expiration (7) during treatment. Without minimizing the motion magnitude, a large planning margin is required to ensure adequate tumor dose coverage, thus potentially exposing healthy liver tissue to unsafe radiation exposure. Liver motion management for SBRT is therefore essential (8) .
Stereoscopic X-ray imagers installed in the treatment rooms have often been used to monitor tumor motion during treatment. These X-ray imagers can only visualize bony structures or implanted metal markers. Ultrasound images have advantages in visualizing certain soft tissues such as the liver, and have been used to localize the prostate in radiotherapy (9, 10) . Furthermore, ultrasound imaging offers other advantages compared to X-ray imaging modalities. Ultrasound is relatively inexpensive and does not require ionization. Ultrasound imaging alone, however, may not be sufficient to establish an accurate spatial relationship between the tumor and the radiation center (9) . Recently, a robotically controlled ultrasound that is integrated with the kilo-voltage cone-beam computed tomography (KV-CBCT) system has been proposed (11, 12) . The KV-CBCT systems have been routinely used for image-guided radiotherapy delivery. Obtaining patients' volumetric anatomy has been the major advantage of the KV-CBCT over the conventional 2-dimensional (2D) portal images (or radiographies). Integrating KV-CBCT with ultrasound imaging can provide complemented volumetric information of the tumor and reference bony structures. Furthermore, robotic controlling of the ultrasound probe can improve reproducibility of the probe positioning and applied pressure. Most importantly, ultrasound enables real-time soft tissue monitoring during treatment. With real-time ultrasound monitoring, our challenge is that the ultrasound probe, which is often placed in the shortest pathway to the liver tumor, may block the radiation beams optimally directed to the tumor. The purpose of this study was to investigate the feasibility of altering orientations of the ultrasound probe and directions of radiation beams to minimize the interference between the ultrasound probe and radiation beams without compromising treatment plan quality.
Materials and Methods

Patients
Ten patients with hepatic tumors were randomly selected for this planning study from patients who received SBRT treatment at Cleveland Clinic from May 2009 to February 2011. The Institutional Review Board at Cleveland Clinic approved this retrospective, low-risk study. The patient population included 7 men and 3 women, with a mean age of 61 years (range: 46 to 74 years). The median gross tumor volume (GTV) was 106.22 cm 3 (range: 15.90 cm 3 to 231.58 cm 3 ). Each patient had a single target volume delineated for SBRT treatment. Most patients had primary liver tumors, with 3 tumors located in liver segment 8, 3 tumors in liver segment 6, and 1 tumor in each liver segments 7, 5, 4 and 2.
Volume Definitions and SBRT Planning
The GTV was manually delineated by the attending radiation oncologist on the treatment planning computed tomography (CT) images. The clinical target volume (CTV) was defined as 4 mm uniform expansion of the GTV within the boundary of the liver in order to include the potential microscopic disease. The planning target volume (PTV) was defined as a 3 mm uniform expansion of the CTV to allow for the set-up uncertainty. The treatment goal was to deliver 37.5 Gy to the PTV in 3 fractions over one week. On each planning CT, the following selected organs at risk (OAR) were also delineated: healthy liver, spinal cord, heart (hepatic artery, hepatic vein), kidneys, esophagus, lungs, and stomach.
A typical liver SBRT plan utilized 5 to 7 intensity-modulated radiation (IMRT) beams delivered with a step-and-shoot method under an active breathing control (ABC) device (Elektra Oncology, Norcross, GA) to control the liver motion during SBRT delivery. The SBRT plans were delivered with 6 MV using a Novalis Tx (Varian, Palo Alto, CA) linear accelerator, with a dose rate of 1,000 monitor unit/minute. The IMRT plans were optimized using the Direct Machine Parameter Optimization in the Pinnacle treatment planning system (version 8.0m, Philips Healthcare, Fitchburg, WI). All SBRT plans were normalized so that at least 95% of the PTV received the prescription dose of 37.5 Gy. Table I lists typical plan acceptance criteria for relevant OARs.
Plans with Simulated Ultrasound Probe
The robotically controlled ultrasound probe is similar to conventional ultrasound probes with dimensions of 20 mm (width) 3 70 mm (length) 3 50 mm (height). To simulate the placement of the ultrasound probe, we incorporated a virtual rectangular block of 20 mm 3 70 mm 3 50 mm on the planning CT, placing the block on the surface of the patient's body Figure  1 ). For each patient, we created 2 additional SBRT plans with the virtual ultrasound block in the parallel position (referred to as Probe-Para plans) and with the virtual ultrasound block in the vertical position (referred to as Probe-Vert plans) avoiding the intersection of radiation beams by the block. The planning objectives for the Probe-Para and Probe-Vert plans were to achieve the same target coverage and sparing of OARs as the clinical SBRT plans. For the Probe-Para and Probe-Vert plans, radiation beam directions were adjusted from those of clinical SBRT plans to avoid the exposure of the probe.
Choice of Radiation Beam Directions
Without the ultrasound probe, all clinical SBRT plans used coplanar beams. Figure 2A shows a diagram of 6 coplanar beams, which are delivered by simply rotating the gantry of a linear accelerator without moving the treatment couch. Use of coplanar beams is advantageous to reduce treatment time and avoiding the potential risk of collision between the gantry and the patient. Non-coplanar beams, however, are delivered by rotating the gantry and the treatment couch, which requires a therapist to physically move the couch or use video surveillance to move the couch remotely. Figure  2B shows a diagram of 6 non-coplanar beams, in which 2 of the non-planar beams direct to the superior and inferior areas of the patient. The use of non-coplanar beams usually prolongs the treatment delivery time and may increase the risk of collision between the gantry and the patient.
Planning Assessment
The target coverage and target dose distribution were evaluated with the following defined endpoints: the minimal dose to 95% (D 95 ) of the PTV, mean dose (D mean ) to the PTV, percentage (V 37.5 ) of the PTV receiving the prescription dose of 37.5 Gy, conformal index (CI), and homogeneity index (HI). The CI was defined as the ratio between the target volume and the volume encompassing the prescription isodose line (13) . The HI was defined as the ratio of the maximum dose of the entire plan to the prescription dose of the plan (14) .
For healthy liver (referred to as the liver in the remainder of this paper), the mean dose, dose received by 30% (D 30 ), 60% (D 60 ) of the liver volume and the absolute volume (in cc) (V 15 ) of the liver receiving 15 Gy were compared. Other OARs (including kidneys, esophagus, lungs, stomach and heart) were evaluated with the mean dose and the maximum point dose. The dose-volume histograms (DVH) of the target and organs at risk were also used for comparison. A paired sample t-test was used for statistical analysis with significance claimed for values of p  0.05.
Results
Among the 10 patients, radiation beams could not completely avoid the probe block for 2 patients due to superficially located tumors, where the maximum distance from the patient's skin surface to the center of tumor was less than 3 cm. For each of the remaining 8 patients, 3 plans were compared: including one clinical plan and Probe-Para and Probe-Vert plans. Among these plans, the mean number of beams was 6 (range: 5 to 7). Of the Probe-Para plans, for 7 of the 8 patients, the virtual probe was avoided using coplanar beam arrangements. One patient required the use of non-coplanar beams. Of the Probe-Vert plans, for 2 of the 8 patients, the virtual probe was avoided using coplanar beams, whereas the remaining 6 patients required non-coplanar beams.
For a selected patient, Figure 3A shows dose distributions for the clinical plan, Probe-Para, and Probe-Vert Plans. Figure 3B shows the DVH of the PTV and DVHs of selected normal organs. Despite different beam configurations, the 3 plans achieved very similar dose distributions and DVHs because intensity-modulated beams are less sensitive to the choice of beam directions. Table III shows conformal indices for the 3 types of plans. There are no statistical differences among these endpoints in the clinical plans, Probe-Para, and Probe-Vert plans. Table IV summarizes the dose coverage for the normal tissues. All plans met the dose objectives for organs at risk, with no statistical differences among the plans.
Coplanar and Non-coplanar Beam Configurations
For treatment simplicity, coplanar beams were used exclusively in the clinical plans while an ultrasound probe was not present. With the virtual ultrasound probe, non-coplanar beams were needed in Probe-Para and Probe-Vert plans to avoid the interference between the probe and radiation beams, especially for treating larger volume tumors and where the tumor was located near the skin surface. Dosimetrically, the use of noncoplanar beams increased the average D mean to the heart from 1.46 Gy to 1.98 Gy; increased D mean to the right lung from 3.56 Gy to 4.38 Gy and to the right kidney from 1.32 Gy to 2.04 Gy. However, the use of non-coplanar beams decreased the maximum dose from 2.62 Gy to 2.04 Gy to the spinal cord in 2 patients and decreased the maximum dose from 1.60 Gy to 0.85 Gy to the esophagus in 3 patients. These dosimetric changes are minor and clinically insignificant.
Discussion
Treatment uncertainties in liver SBRT can be large, partly due to intra-and inter-fraction organ motions. Imaging-guided radiotherapy has significantly reduced these uncertainties (15) (16) (17) and has evolved from early 2D portal films to current multiple imaging modalities including ultrasound, optical imaging, and CBCT (18, 19) . These imaging systems have been proven to improve the precision of patient positioning and target localization before treatment (20) (21) (22) (23) . Monitoring soft tissue tumor motion during treatment, however, is still a challenge. Realtime tumor motion detection, such as the use of electromagnetic transponders in the Calypso system (Calypso Medical, Seattle, WA), is limited to the prostate (24, 25) . Kilo-voltage X-ray fluoroscopy with implanted fiducial markers can track the lung tumor during treatment but requires excessive radiation exposure. Furthermore, implantation of the fiducial markers is invasive with a potential risk of pneumothorax and bleeding (26) .
Other imaging methods, such as stereoscopic X-ray systems, provide frequent snapshots to monitor the tumor motion (27) . None of these methods can be satisfactorily applied to monitoring liver tumor motion due to the lack of soft tissue contrast.
Ultrasound provides a means of noninvasive, non-ionization, relatively easy and inexpensive real-time imaging modality for soft tissue, including the liver and the prostate (28, 29) . The use of ultrasound imaging has improved the daily target localization accuracy for patients with prostate cancer (30, 31) . An alternative option to improving soft tissue visualization is the use of an on-board magnetic resonant imaging system. The integration of the KV-CBCT with a robot-controlled autoscan ultrasound system would be less expensive, capable of correcting patient setup errors, localizing soft tissue tumors, and monitoring tumor motion during treatments (32) .
For patients with inoperable liver tumors, alternative options may be chemoembolization or radiofrequency ablation (RFA). RFA is an invasive procedure and may have a risk of perforation of the diaphragm or pneumothroax. It may also be affected by the proximity of the large vessels. In contrast, SBRT is a non-invasive, outpatient procedure. Furthermore, SBRT can also effectively treat tumors located near large vessels where RFA may loose its efficacy due to loss of heat.
Our results showed that for most patients with liver tumors, real-time ultrasound monitoring had no negative effect on the treatment plan. Our simulated plans achieved similar dose coverage of the tumor target and similar protection of normal tissue as the previously accepted clinical treatment plans. When the ultrasound probe was positioned parallel to the longitudinal axis of the body, slight adjustment of the beam angle configuration could avoid radiation beams intersecting the ultrasound probe. Alternatively, one can change the insonation angle, or the angle of the ultrasound probe, to provide better access of the radiation beams while not compromising ultrasound imaging quality. This will require a new study to investigate the feasibility of changing the ultrasound insonation angle to accommodate radiation beams.
For large tumor volumes, we found that the non-coplanar technique may be necessary. Although there were no significant differences in doses of the normal tissue among all plans compared, there were some minor yet clinically insignificant changes in radiation doses of certain organs. For superficially located tumors, radiation beams could not completely avoid the probe while keeping the same plan quality as the previously accepted clinical plans. Alternatively, the probe may be placed in other locations, not in the location nearest the tumor, which may compromise imaging quality of the ultrasound.
Conclusions
For most patients, real-time ultrasound monitoring during SBRT is clinically feasible. Placing the ultrasound probe parallel to the longitudinal axis allows greater probability of using coplanar beams. For some patients with tumors located superficially, with real-time ultrasound monitoring, it may be difficult to achieve acceptable treatment plans with quality ultrasound images.
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